Medical News

RSS

SQI Diagnostics signs development agreement with Silliker

SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced that it has entered into a development agreement with Silliker, Inc., a leading internationally accredited company dedicated to improving nutrition, food safety and quality, for the commercialization of a botulism toxin panel that will run on SQI's SQiDman analytical system.

26 Apr 2010

Covidien launches EXALGO Extended-Release Tablets in the US

Covidien, a leading global provider of healthcare products, today introduced EXALGO™ (hydromorphone HCI) Extended-Release Tablets, (CII), the only extended-release hydromorphone treatment available in the United States. This proven therapy, combined with an innovative delivery system, provides opioid-tolerant patients suffering from moderate-to-severe chronic pain relief for 24 hours per dose.

26 Apr 2010

First Edition: April 26, 2010

Today's headlines reflect state-level health policy developments as well as forward-looking stories related to the cost of federal health reforms.

26 Apr 2010

Mikki sponsors National Grooming Week

Mikki, sponsors of National Grooming Week, recognise that the bond between people and animals is a strong one and one which can actually benefit any pet owner. Recent research carried out suggests that owning a pet can help reduce stress levels in humans in a way only they know how!

26 Apr 2010

Study confirms utility of Oxford Immunotec's T-SPOT.TB assay in identifying latent TB infection

The authors of a recent peer-reviewed study published in the International Journal of Tuberculosis and Lung Disease confirmed the high specificity of the T-SPOT.TB assay.

26 Apr 2010

Elderlink offers personalized referral lists for senior citizens and their families

Elderlink, Inc., a free senior care referral service serving California since 1994, is offering senior citizens and their families the ability to find the care they need via personalized referral lists based upon their individual needs.

26 Apr 2010

Investment report featuring Imaging3

MicroStockProfit.com announces an investment report featuring Imaging3 Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

26 Apr 2010

Napo Pharmaceuticals announces formation of Finder's Agreement with Luye Pharma Group

Napo Pharmaceuticals, Inc., which focuses on the development and commercialization of proprietary pharmaceuticals for the treatment of diarrheal diseases in the global marketplace in collaboration with local partners, is pleased to announce the formation of a Finder's Agreement with its licensee for crofelemer in China, Luye Pharma Group Ltd. (formerly Asiapharm).

26 Apr 2010

Humana reports first-quarter EPS of $1.52

Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended March 31, 2010 (1Q10) of $1.52, ahead of management's guidance of $1.10 to $1.20. EPS for 1Q10 included earnings of approximately $0.37 per share from higher-than-anticipated favorable prior-period development of medical claims reserves as well as $0.04 per share in higher-than-projected income tax expense due to recently enacted health reform legislation. Excluding these items, 1Q10 EPS was at the top end of the company's previous guidance range.

26 Apr 2010

Kinetic Concepts introduces V.A.C.Via Therapy System

Kinetic Concepts, Inc. today introduced V.A.C.Via Therapy System, a next-generation negative pressure wound therapy solution that offers clinicians and patients a mobile healing technology with the proven benefits and outcomes of V.A.C. Therapy.

26 Apr 2010

ev3 completes enrollment in study of EverFlex Self-Expanding Stent System for SFA

ev3 Inc. today announced the completion of patient enrollment in the DURABILITY II trial, a prospective, multi-center, single-arm study evaluating the EverFlex® Self-Expanding Stent System for the treatment of superficial femoral artery (SFA) and proximal popliteal lesions. The DURABILITY II study will support a planned Premarket Approval (PMA) filing with the U.S. Food and Drug Administration to obtain approval of the EverFlex Self-Expanding Stent System for use in the SFA.

26 Apr 2010

MicroStockProfit.com releases investment report on Rexahn Pharmaceuticals

MicroStockProfit.com announces an investment report featuring Rexahn Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

26 Apr 2010

Researchers synthesize metal compounds that can be effective in treatment of cancer

Scientists from Bochum have managed to accurately determine the location of metal complexes within living cancer cells using Raman microscopy. The researchers have thus gained new insights into the mechanism of action of metal-containing drugs, to which they ascribe great potential capacities, e.g. in the treatment of cancer.

26 Apr 2010

Reconstructive techniques for degenerative mitral valve disease

Elsevier, the world-leading publisher of scientific, technical and medical information products and services, proudly announces the release of a brand-new single volume comprehensive book on reconstructive techniques for degenerative mitral valve disease by the internationally renowned cardiac surgeon and educator, Dr. Alain Carpentier. The book will launch at the 90th Annual Meeting of the American Association for Thoracic Surgery at the Metro Toronto Convention Centre in Toronto, Ontario, Canada, May 1 - 5, 2010.

26 Apr 2010

Research documents early warning signs resulting from global pullback on AIDS funding

Rationing Funds, Risking Lives: World Backtracks on HIV Treatment, the new report from the International Treatment Preparedness Coalition, documents early warning signs resulting from the global pullback on AIDS commitment and funding: caps on the number of people enrolled in treatment programs, more frequent drug stock outs, and national AIDS budgets falling short.

26 Apr 2010

Beijing Customs seize Biosite's Triage products

Biosite's Triage products imported by Inverness Medical Beijing Co., Ltd. in April 2010 have been seized by Beijing Customs for not complying with the applicable importation regulations. As a result, the Chinese market is facing a severe shortage.

26 Apr 2010

Long telomeres in non-demented adults and seniors associated with poorer memory: Researchers

A team of collaborating researchers from the Swedish universities of Umeå, Stockholm, and Linköping is now publishing data showing that long telomeres in non-demented adults and seniors can be associated with poorer memory.

26 Apr 2010

Vitamin selected as agency of record for IZI Medical Products

The boutique design-web-public relations firm Vitamin® announced today its selection as agency of record for IZI Medical Products, a Maryland-based innovator of medical device accessories. Vitamin is providing IZI with retained public relations services for strengthening overall brand and key product awareness. Additionally, Vitamin is handling product naming and product branding, as well as integrated marketing for refreshing IZI's new corporate messaging, tagline and logo.

26 Apr 2010

Ness Technologies announces implementation of Oracle E-Business Suite at Teva Czech Industries

Ness Technologies, Inc., a global provider of information technology solutions and services, announced today the start of an Oracle E-Business Suite implementation at Teva Czech Industries s.r.o., a provider of pharmaceutical products. The new system will handle financial and logistics issues, replacing a current QAD MFG/Pro system.

26 Apr 2010

Pevion Biotech to present positive results of PEV4 RSV vaccine candidate at Vaccine Innovation Meeting

Pevion Biotech, the Swiss vaccine company, today announced that it has successfully completed the preclinical safety and efficacy studies of its RSV vaccine candidate PEV4. The vaccine candidate is a modern subunit vaccine candidate against respiratory syncytial virus (RSV), which is based on a recombinant RSV-F protein formulated with Pevion Biotech's proprietary and market-validated virosome technology platform.

26 Apr 2010

Medical News

SQI Diagnostics signs development agreement with Silliker

Covidien launches EXALGO Extended-Release Tablets in the US

First Edition: April 26, 2010

Mikki sponsors National Grooming Week

Study confirms utility of Oxford Immunotec's T-SPOT.TB assay in identifying latent TB infection

Elderlink offers personalized referral lists for senior citizens and their families

Investment report featuring Imaging3

Napo Pharmaceuticals announces formation of Finder's Agreement with Luye Pharma Group

Humana reports first-quarter EPS of $1.52

Kinetic Concepts introduces V.A.C.Via Therapy System

ev3 completes enrollment in study of EverFlex Self-Expanding Stent System for SFA

MicroStockProfit.com releases investment report on Rexahn Pharmaceuticals

Researchers synthesize metal compounds that can be effective in treatment of cancer

Reconstructive techniques for degenerative mitral valve disease

Research documents early warning signs resulting from global pullback on AIDS funding

Beijing Customs seize Biosite's Triage products

Long telomeres in non-demented adults and seniors associated with poorer memory: Researchers

Vitamin selected as agency of record for IZI Medical Products

Ness Technologies announces implementation of Oracle E-Business Suite at Teva Czech Industries

Pevion Biotech to present positive results of PEV4 RSV vaccine candidate at Vaccine Innovation Meeting

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News